C190H268F7N35O22S — CID 157061450
N-[(2S)-4-(azepan-1-yl)-1-[[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]amino]-1,4-dioxobutan-2-yl]-4-methylpentanamide;(2S)-2-(3-cyclopropylpropanoylamino)-N-[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]-4-[(2S)-2-methylpiperidin-1-yl]-4-oxobutanamide;(2S)-2-(ethylsulfonylamino)-N-[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]-4-[(2S)-2-methylpiperidin-1-yl]-4-oxobutanamide;N-[(2S)-1-[[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]amino]-1,4-dioxo-4-piperidin-1-ylbutan-2-yl]-4-methylpentanamide;N-[(2S)-1-[[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]amino]-4-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxobutan-2-yl]-4-methylpentanamide;N-[(2S)-1-[[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]amino]-4-[(2S)-2-methylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide;(2S)-N-[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]-2-[(3-methyl-2-oxobutyl)amino]-4-[(2S)-2-methylpiperidin-1-yl]-4-oxobutanamide (PubChem CID 157061450) has the molecular formula C190H268F7N35O22S and a molecular weight of 3559.51 g/mol. Its IUPAC name is N-[(2S)-4-(azepan-1-yl)-1-[[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]amino]-1,4-dioxobutan-2-yl]-4-methylpentanamide;(2S)-2-(3-cyclopropylpropanoylamino)-N-[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]-4-[(2S)-2-methylpiperidin-1-yl]-4-oxobutanamide;(2S)-2-(ethylsulfonylamino)-N-[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]-4-[(2S)-2-methylpiperidin-1-yl]-4-oxobutanamide;N-[(2S)-1-[[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]amino]-1,4-dioxo-4-piperidin-1-ylbutan-2-yl]-4-methylpentanamide;N-[(2S)-1-[[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]amino]-4-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxobutan-2-yl]-4-methylpentanamide;N-[(2S)-1-[[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]amino]-4-[(2S)-2-methylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide;(2S)-N-[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]-2-[(3-methyl-2-oxobutyl)amino]-4-[(2S)-2-methylpiperidin-1-yl]-4-oxobutanamide.
| Compound Name | N-[(2S)-4-(azepan-1-yl)-1-[[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]amino]-1,4-dioxobutan-2-yl]-4-methylpentanamide;(2S)-2-(3-cyclopropylpropanoylamino)-N-[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]-4-[(2S)-2-methylpiperidin-1-yl]-4-oxobutanamide;(2S)-2-(ethylsulfonylamino)-N-[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]-4-[(2S)-2-methylpiperidin-1-yl]-4-oxobutanamide;N-[(2S)-1-[[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]amino]-1,4-dioxo-4-piperidin-1-ylbutan-2-yl]-4-methylpentanamide;N-[(2S)-1-[[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]amino]-4-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxobutan-2-yl]-4-methylpentanamide;N-[(2S)-1-[[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]amino]-4-[(2S)-2-methylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide;(2S)-N-[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]-2-[(3-methyl-2-oxobutyl)amino]-4-[(2S)-2-methylpiperidin-1-yl]-4-oxobutanamide |
|---|---|
| PubChem CID | 157061450 |
| Molecular Formula | C190H268F7N35O22S |
| Molecular Weight | 3559.51 g/mol |
| Exact Mass | 3557.05 |
| IUPAC Name | N-[(2S)-4-(azepan-1-yl)-1-[[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]amino]-1,4-dioxobutan-2-yl]-4-methylpentanamide;(2S)-2-(3-cyclopropylpropanoylamino)-N-[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]-4-[(2S)-2-methylpiperidin-1-yl]-4-oxobutanamide;(2S)-2-(ethylsulfonylamino)-N-[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]-4-[(2S)-2-methylpiperidin-1-yl]-4-oxobutanamide;N-[(2S)-1-[[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]amino]-1,4-dioxo-4-piperidin-1-ylbutan-2-yl]-4-methylpentanamide;N-[(2S)-1-[[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]amino]-4-[(2S)-2-methylpiperidin-1-yl]-1,4-dioxobutan-2-yl]-4-methylpentanamide;N-[(2S)-1-[[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]amino]-4-[(2S)-2-methylpyrrolidin-1-yl]-1,4-dioxobutan-2-yl]-4,4-dimethylpentanamide;(2S)-N-[(1S)-1-[5-(2-fluoro-4-methylphenyl)-1H-imidazol-2-yl]ethyl]-2-[(3-methyl-2-oxobutyl)amino]-4-[(2S)-2-methylpiperidin-1-yl]-4-oxobutanamide |
| SMILES | CCS(=O)(=O)N[C@@H](CC(=O)N1CCCC[C@@H]1C)C(=O)N[C@@H](C)c1ncc(-c2ccc(C)cc2F)[nH]1.Cc1ccc(-c2cnc([C@H](C)NC(=O)[C@H](CC(=O)N3CCCCC3)NC(=O)CCC(C)C)[nH]2)c(F)c1.Cc1ccc(-c2cnc([C@H](C)NC(=O)[C@H](CC(=O)N3CCCCCC3)NC(=O)CCC(C)C)[nH]2)c(F)c1.Cc1ccc(-c2cnc([C@H](C)NC(=O)[C@H](CC(=O)N3CCCC[C@@H]3C)NC(=O)CCC(C)C)[nH]2)c(F)c1.Cc1ccc(-c2cnc([C@H](C)NC(=O)[C@H](CC(=O)N3CCCC[C@@H]3C)NC(=O)CCC3CC3)[nH]2)c(F)c1.Cc1ccc(-c2cnc([C@H](C)NC(=O)[C@H](CC(=O)N3CCCC[C@@H]3C)NCC(=O)C(C)C)[nH]2)c(F)c1.Cc1ccc(-c2cnc([C@H](C)NC(=O)[C@H](CC(=O)N3CCC[C@@H]3C)NC(=O)CCC(C)(C)C)[nH]2)c(F)c1 |
| InChI | InChI=1S/C28H38FN5O3.3C28H40FN5O3.2C27H38FN5O3.C24H34FN5O4S/c1-17-7-11-21(22(29)14-17)24-16-30-27(33-24)19(3)31-28(37)23(32-25(35)12-10-20-8-9-20)15-26(36)34-13-5-4-6-18(34)2;1-17-9-10-20(21(29)14-17)23-16-30-26(33-23)19(3)31-27(37)22(32-24(35)11-12-28(4,5)6)15-25(36)34-13-7-8-18(34)2;1-17(2)9-12-25(35)32-23(15-26(36)34-13-7-6-8-19(34)4)28(37)31-20(5)27-30-16-24(33-27)21-11-10-18(3)14-22(21)29;1-18(2)9-12-25(35)32-23(16-26(36)34-13-7-5-6-8-14-34)28(37)31-20(4)27-30-17-24(33-27)21-11-10-19(3)15-22(21)29;1-16(2)24(34)15-29-22(13-25(35)33-11-7-6-8-18(33)4)27(36)31-19(5)26-30-14-23(32-26)20-10-9-17(3)12-21(20)28;1-17(2)8-11-24(34)31-22(15-25(35)33-12-6-5-7-13-33)27(36)30-19(4)26-29-16-23(32-26)20-10-9-18(3)14-21(20)28;1-5-35(33,34)29-20(13-22(31)30-11-7-6-8-16(30)3)24(32)27-17(4)23-26-14-21(28-23)18-10-9-15(2)12-19(18)25/h7,11,14,16,18-20,23H,4-6,8-10,12-13,15H2,1-3H3,(H,30,33)(H,31,37)(H,32,35);9-10,14,16,18-19,22H,7-8,11-13,15H2,1-6H3,(H,30,33)(H,31,37)(H,32,35);10-11,14,16-17,19-20,23H,6-9,12-13,15H2,1-5H3,(H,30,33)(H,31,37)(H,32,35);10-11,15,17-18,20,23H,5-9,12-14,16H2,1-4H3,(H,30,33)(H,31,37)(H,32,35);9-10,12,14,16,18-19,22,29H,6-8,11,13,15H2,1-5H3,(H,30,32)(H,31,36);9-10,14,16-17,19,22H,5-8,11-13,15H2,1-4H3,(H,29,32)(H,30,36)(H,31,34);9-10,12,14,16-17,20,29H,5-8,11,13H2,1-4H3,(H,26,28)(H,27,32)/t18-,19-,23-;18-,19-,22-;19-,20-,23-;20-,23-;18-,19-,22-;19-,22-;16-,17-,20-/m0000000/s1 |
| InChIKey | ABJNCTQSCLPQKJ-HWWZOCEGSA-N |
| XLogP | 27.91 |
| TPSA | 767.40 Ų |
| H-Bond Donors | 21 |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 68 |
| Heavy Atoms | 255 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3559.51 |
| LogP ≤ 5 | 27.91 |
| H-Bond Donors ≤ 5 | 21 |
| H-Bond Acceptors ≤ 10 | 30 |